MicroRNA-34a regulates cardiac ageing and function.
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Ageing is the predominant risk factor for cardiovascular diseases and contributes to a significantly worse outcome in patients with acute myocardial infarction. MicroRNAs (miRNAs) have emerged as crucial regulators of cardiovascular function and some miRNAs have key roles in ageing. We propose that altered expression of miRNAs in the heart during ageing contributes to the age-dependent decline in cardiac function. Here we show that miR-34a is induced in the ageing heart and that in vivo silencing or genetic deletion of miR-34a reduces age-associated cardiomyocyte cell death. Moreover, miR-34a inhibition reduces cell death and fibrosis following acute myocardial infarction and improves recovery of myocardial function. Mechanistically, we identified PNUTS (also known as PPP1R10) as a novel direct miR-34a target, which reduces telomere shortening, DNA damage responses and cardiomyocyte apoptosis, and improves functional recovery after acute myocardial infarction. Together, these results identify age-induced expression of miR-34a and inhibition of its target PNUTS as a key mechanism that regulates cardiac contractile function during ageing and after acute myocardial infarction, by inducing DNA damage responses and telomere attrition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“miR 124, miR-34a/b/c, and miR-29a/b/c are upregulated in response to p53 activation and facilitate cellular senescence by downregulating survival and cell proliferation factors (Hermeking, 2010; Boon et al., 2013; Hu et al., 2014; Xu S. et al., 2019).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Boon et al., 2013
Citations
Cites
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Telomere measurement by quantitative PCR
Cawthon, R. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.10.e47 · Cited by 3,487
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
Identifying differentially expressed genes using false discovery rate controlling procedures
Reiner, A., Yekutieli, D., & Benjamini, Y. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btf877 · Cited by 1,765
miR-34a repression of SIRT1 regulates apoptosis
Yamakuchi, M., Ferlito, M., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801613105 · Cited by 1,342
Telomere dysfunction induces metabolic and mitochondrial compromise
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., et al. (2011) · Nature · doi:10.1038/nature09787 · Cited by 1,319
MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
Bonauer, A., Carmona, G., Iwasaki, M., Mione, M., Koyanagi, M., Fischer, A., Burchfield, J., Fox, H., Doebele, C., Ohtani, K., et al. (2009) · Science · doi:10.1126/science.1174381 · Cited by 1,215
Self-citationPervasive roles of microRNAs in cardiovascular biology
Small, E. M., & Olson, E. N. (2011) · Nature · doi:10.1038/nature09783 · Cited by 1,180
Cited by
Items 801–828 of 828
García‐Mendívil, L., Pueyo, E., & Vidal, L. O. (2023) · Zaguan (Universidad de Zaragoza)
Análisis de los microRNA en enfermedades cardiovasculares y envejecimiento cardiaco
Bellido, N. H., Vidal, L. O., & Ramos-Marquès, E. (2020) · Zaguan (University of Zaragoza Repository)
Role of ncRNAs in Neurological Disorders and Cardiovascular Diseases
Sajid, M. I., Khan, F. A., Mohsin, H., Maqbool, M. B., Mahmood, F., Yaseen, M., Younas, M., Naziri, A., Haider, K. H., & Tiwari, R. K. (2026) · Experientia supplementum · doi:10.1007/978-3-032-06948-1_2
Post-transcriptional regulation in intervertebral disc degeneration
Li, X., Liang, H., Du, Z., Shi, R., Song, Y., & Yang, C. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102037
RNA editing in cardiovascular health and disease
Huang, X., Solomon, C. U., McVey, D. G., & Ye, S. (2026) · Communications Biology · doi:10.1038/s42003-026-09680-1
“A previous study by Boon et al. showed that silencing or genetic deletion of microRNA-34a reduced cardiomyocyte cell death and fi brosis following acute myocardial infarction in an animal model 57 .”
ORANGE: a machine learning approach for modeling tissue-specific aging from transcriptomic data
Jalal, W., Musarrat, M., Samee, M. A. H., & Rahman, M. S. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag093 · Cited by 1
Senescence-related myocardial dysfunction: keeping a young heart
Christopher, G., George, C. H., Kanamarlapudi, V., & Higginbotham, V. (2026) · Cronfa (Swansea University)
Hénaoui, I. S. (2013) · theses.fr (ABES) · doi:10.70675/9b5eefb2zda67z4abezb5a7z715be0b8c813
Les microARN : biomarqueurs et cibles thérapeuthiques des maladies cardiovasculaires
Goretti, E. (2014) · theses.fr (ABES) · doi:10.70675/085956a9zae71z4281zb1fcz679f54d56996
Implication de la voie p53 et du microARN miR-34a dans la résistance à l'insuline adipocytaire
Cornejo, P.-J. (2014) · theses.fr (ABES) · doi:10.70675/56e75b3az9d59z4e97za195z3b0924c37e0b
Varghese, L. N. (2026) · Otago University Research Archive (University of Otago) · doi:10.82348/our-archive.00122
Cardiovascular Dysfunction in Type 2 Diabetes: The Role of MicroRNAs
Kayki‐Mutlu, G., & Arioglu-Inan, E. (2026) · Handbook of experimental pharmacology · doi:10.1007/164_2026_799
Díaz-Rosas, G., Gómez-Acuña, O., Saucedo, R., Chávez-García, R., Reyes‐López, A., Contreras‐Ramos, A., & Ortega‐Camarillo, C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104368
“Furthermore, the regulation of SIRT1 by miR-34a has been associated with cardiac damage in various pathologies, including acute myocardial infarction, diabetic cardiomyopathy [31], and cardiac aging [32].”
Stefani, S. D., Cimino, M., Tinnirello, R., Cocco, M. M., Chinnici, C. M., Amico, G., Felice, V. D., Macaluso, F., Douradinha, B. G., Nardo, P. D., et al. (2026) · Cells · doi:10.3390/cells15100900
“LNA34 antisense (Ant34) showed a positive effect in vitro on human cardiac progenitors [20] and in vivo on MI mice models [21].”
Różycka-Kosmalska, M., Szymczak-Pajor, I., Śliwińska, A., Kozłowska, M., Wranicz, J. K., & Kosmalski, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125633
“These interactions form a positive feedback loop linked to apoptosis, senescence, oxidative stress, and cardiovascular aging [22,32,33].”
ORMDL3 as Key Regulator of Endothelial Dysfunction in Atherosclerosis via Sphingolipid Biosynthesis
Wang, L. S., Yun, Y., Song, Y. N., Zhao, D., Li, J., Zhang, S., Wang, Z., & Ma, X. (2026) · Inflammation · doi:10.1007/s10753-026-02546-y
“In the cardiovascular system, miR-34a influences vascular inflammation and the progression of AS [ 29 , 48, 49].”
Cardiac regeneration and repair: the emerging mechanisms and therapeutic approaches
Li, Y., Zheng, K., Liu, Y., Li, R., Wang, S., Ye, W., Luo, Z., Li, X., Tao, Z., Xia, J., et al. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00504-6
Su, Z., Shen, H., Sun, J., Kong, X., & Sun, W. Y. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.126.049049
Aldabaan, N. A., Abdel‐Wahab, B. A., El‐Shoura, E. A. M., Alqahtani, S. M., Bakir, M. B., Saad, . M., Omar, Z. M. M., & Zaafar, D. K. (2026) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2026.2713465
Sakashita, Y., Miyamoto, S., Sagara, M., Ito, S., Kobayashi, Y., MOMODA, Y., Yano, F., Eto, K., Tani, K., & Murahashi, M. (2026) · Molecular Therapy Oncology · doi:10.1016/j.omton.2026.201332
“16,18,19 Consistent with these properties, our previous study demonstrated that miR-34a is abundantly expressed in normal cardiac and pancreatic tissues, while exhibiting reduced expression in several tumor types, including lung cancer.”
Wang, L., Zhao, Y., Zhang, R., Ning, X., & Jin, B. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177793
“These studies provide cardiac perturbation evidence, while also showing why therapeutic direction depends on cell type: miR-29 can restrain fibrosis yet alter genome-maintenance pathways [105,106].”
Ebrahimi‐Dehkordi, S., Barjasteh, A. H., Zarei, A., Bazmi, S., Vaseghi, S., Ashna, S., Solati, A., Yousefzadeh, A., Nasrabad, B. S., Mohammadi, Z., et al. (2026) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.70310
Liao, J., Li, C., Zheng, M., 石瑞正, & Liu, Z. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103963
Loss of CDON aggravates age-related heart damage driven by compromised FOXO3 nuclear localization
Chen, L., Liu, H., Long, C., Zhan, W., Tian, X.-L., & Chen, S. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168502
Zhai, S., Wang, Z., Wang, J., Guo, X., Tan, X., Zhang, H., Zhang, R., & Hu, N. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6c15728
Yadav, P., Bhakta-Guha, D., Nagarajan, D., Mani, K. P., Mondal, R., Guha, G., & Kurian, G. A. (2026) · Cardiovascular Toxicology · doi:10.1007/s12012-026-10209-5
“Selected regulatory microRNAs provide another component of Tier 2. miR-34a has been experimentally implicated in cardiac aging and functional decline [ 62], whereas miR-146a/b can regulate senescence-associated inflammatory mediators including IL-6 and IL-8 [ 61].”
Kim, S., & Jazwinski, S. M. (2015) · Molecular and integrative toxicology · doi:10.1007/978-1-4471-6678-8_8 · Cited by 1
Metadata
- Authors
- Boon, R. A., Iekushi, K., Lechner, S., Seeger, T., Fischer, A., Heydt, S., Kaluza, D., Tréguer, K., Carmona, G., Bonauer, A., Horrevoets, A. J. G., Didier, N., Girmatsion, Z., Biliczki, P., Ehrlich, J. R., Katus, H. A., Müller, O. J., Potente, M., Zeiher, A. M., Hermeking, H., & Dimmeler, S.
- Affiliations
- Goethe University Frankfurt (DE)
- Pathologisches Institut (DE)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Inserm (FR)
- Heidelberg University (DE)
- Corresponding author
- Dimmeler, Stefanie
- ORCID
- Venue
- Nature
- Published
- 2013-02-20
- Volume
- 495
- Issue
- 7439
- Pages
- 107-110
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2090374150
- Cited by
- 821
- References
- 36
- Citations by year
- 2026: 29 · 2025: 37 · 2024: 41 · 2023: 42 · 2022: 64 · 2021: 45 · 2020: 61 · 2019: 59 · 2018: 72 · 2017: 84 · 2016: 75 · 2015: 85 · 2014: 90 · 2013: 34
- FWCI
- 33.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- miR-34a, cardiac aging, PNUTS, microRNA regulation, cardiomyocyte apoptosis, telomere shortening, DNA damage response, myocardial fibrosis, acute myocardial infarction, cardiac contractile function, therapeutic target
- MeSH terms
- Aging, Animals, DNA Damage, Fibrosis, Gene Expression Regulation, Heart, Mice, Inbred C57BL, Myocardial Infarction, Myocardium, Substrate Specificity, Genetic Therapy, Telomere, Apoptosis, Gene Deletion, Myocytes, Cardiac, MicroRNAs, Mice, Gene Knockout Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.